Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.
Clinical trial NCT01625182 · COMPLETED
Trial details
- NCT number
- NCT01625182
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-22
- Primary completion
- 2016-09-03
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.